checkAd

     138  0 Kommentare ImmunityBio To Present Data From Multiple Clinical Trials at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - Seite 2


    Business Wire (engl.)
    0 Follower
    Autor folgen
    Seite 2 von 2

    ImmunityBio To Present Data From Multiple Clinical Trials at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - Seite 2 ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced today its abstracts were accepted for presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, June 3-7, in Chicago. QUILT 3.032 Oral …

    Schreibe Deinen Kommentar

    Disclaimer